• If risk of cardiovascular disease is moderate, then a CRP test may help direct further medical evaluation and treatment, with alow CRP supporting conservative intervention and a high CRP supporting more aggressive intervention.
(Benefits of this strategy are notcurrently validated.)
• An individual athigh risk, or with a history of heart disease or stroke, is treated intensively whether CRP is elevated or not, so a CRP test is notwarranted unless the individual is hospitalized with an acute event.
R 'annon, data entry clerk, approached Jackie in the breakoom and asked, HI just skimmed over a news magazine while waiting in line at the grocery store. The featured story announced that having a blood test to measure my C-reactive protein level could save my life by predicting whether or not I might have a heart attack. Why didn't we get that test done at the annual company health fair last week?" Jackie, the occupational health nurse, was familiar with current information on this topic, and was unconvinced that routine testing was warranted for all employees.
C-reactive protein (CRP) is a nonspecific marker for inflammation (EIgharib, Chi, Younis, Wehbe, & Krishnaswamy, 2003) . Exercise, weight loss, and the use of cholesterol-lowering drugs have been shown to decrease CRP levels in humans (Comarow,2004; Elgharib et aI., 2(03) . Physical conditions that may increase levelsof CRP include (Elgharib et al., 2003; Hackam & Shumak, 2004; Thfts University, 2004 
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From American Heart Association. (2005). media to assert that the test might be a valuable routine health-screening tool for most adult Americans. A full assessment of available scientific information does not necessarily support or refute this assertion (Hackam & Shumak, 2004) .
Investigations have confirmed the association between high levels of CRP and the risk of recurrent inpatient ischemic episodes, MI, and sudden cardiac death in individuals hospitalized with serious cardiac events, such as unstable angina and MI (Elgharib et aI., 2003) . In other words, "Higher CRP levels are strong predictors of recurrent events, whereas low CRP levels suggest a good outcome" (Elgharib et al., 2003, p. 3) . It has also been found that, during the course of an 8-year study, women 45 years and older with lower CRP levels tended to have lower blood pressure and fewer MIs, strokes, and bypass surgeries than women with elevated CRP levels (Tufts University, 2004) . Results from studies involving special or diverse ethnic populations are not in evidence, nor have studies addressed the question of whether CRP screening improves long-term patient outcomes (Hackam & Shumak, 2004) . Current recom-mendations from the American Heart Association related to CRP testing for adults are listed in the Sidebar.
Current evidence seems to support the usefulness of CRP monitoring in hospitalized individuals diagnosed with acute cardiac events,and as a diagnostic aid for individuals at moderate risk for cardiovasculardisease.Efficacyas a general health-screening tool has not been established. Future study will clarify the most effectiveuse of CRP monitoringrelated to heart disease risk and MI.
